These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1647559)

  • 1. Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient.
    Ho M
    Transplant Proc; 1991 Apr; 23(2 Suppl 1):2-7. PubMed ID: 1647559
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus infection in patients with solid-organ transplant. Recently reviewed immunologic response and pathogenicity mechanisms.
    Caltenco-Serrano R; Sánchez-Huerta JL; Vargas-Jiménez R; Rodríguez-Suárez RS; Gómez-Barreto D
    Rev Latinoam Microbiol; 2001; 43(4):177-82. PubMed ID: 17061506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance.
    Fildes JE; Yonan N; Leonard CT
    Transpl Immunol; 2008 Apr; 19(1):1-11. PubMed ID: 18346631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus: a viral complication in transplantation.
    van Zanten J; de Leij L; Prop J; Harmsen MC; The TH
    Clin Transplant; 1998 Jun; 12(3):145-58. PubMed ID: 9642503
    [No Abstract]   [Full Text] [Related]  

  • 5. Update in transplantation 1995.
    Helderman JH; Goral S
    Clin Transpl; 1995; ():323-50. PubMed ID: 8794278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is immune tolerance just a chimera?].
    Fasoli G
    G Ital Nefrol; 2008; 25(3):272. PubMed ID: 18473293
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-delta T cell expansion is closely associated with cytomegalovirus infection in all solid organ transplant recipients.
    Couzi L; Lafarge X; Pitard V; Neau-Cransac M; Dromer C; Billes MA; Lacaille F; Moreau JF; Merville P; Déchanet-Merville J
    Transpl Int; 2011 May; 24(5):e40-2. PubMed ID: 21463369
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytomegalovirus-associated allograft rejection in heart transplant patients.
    Potena L; Valantine HA
    Curr Opin Infect Dis; 2007 Aug; 20(4):425-31. PubMed ID: 17609604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant issues: infections and immunosuppressant drugs.
    Giuliano KK; Sims TW
    Dimens Crit Care Nurs; 1999; 18(2):16-9. PubMed ID: 10640004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus infection in organ transplant recipients.
    Hibberd PL; Snydman DR
    Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection.
    van den Berg AP; van Son WJ; Tegzess AM; The TH
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1419-20. PubMed ID: 7680157
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
    Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
    J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus and rejection.
    Goral S; Helderman JH
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):5-6. PubMed ID: 7940975
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts.
    Yagyu K; van Breda Vriesman PJ; Duijvestijn AM; Bruggeman CA; Steinhoff G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1152-4. PubMed ID: 8382853
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunology of cytomegalovirus: immunosuppressive effects during infections.
    Ho M
    Birth Defects Orig Artic Ser; 1984; 20(1):131-47. PubMed ID: 6203569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of direct and indirect effects of cytomegalovirus.
    Kamar N; Mengelle C; Rostaing L
    Exp Clin Transplant; 2007 Dec; 5(2):727-30. PubMed ID: 18194133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.